Key result
Pharmacological intervention for comatose patients with epileptiform abnormalities after cardiac arrest is supported by TELSTAR trial evidence, challenging conventional non-treatment practices.
Why the study?
Does pharmacological intervention improve outcomes in comatose patients with epileptiform abnormalities after cardiac arrest?
Does pharmacological intervention improve outcomes in comatose patients with epileptiform abnormalities after cardiac arrest?
This Viewpoint argues against the conventional practice of withholding pharmacological treatment for epileptiform abnormalities in comatose patients post-cardiac arrest.
This Viewpoint challenges conventional clinical practice that eschews pharmacological intervention for comatose patients with epileptiform abnormalities after cardiac arrest using evidence from the Treatment of Electroencephalographic Status Epilepticus after Cardiopulmonary Resuscitation (TELSTAR) trial.
No takes yet. Share an insight, caveat, or question.
Rossetti et al. (2024) studied this question. Pharmacological intervention for comatose patients with epileptiform abnormalities after cardiac arrest is supported by TELSTAR trial evidence, challenging conventional non-treatment practices.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: